# Orbimed Advisors LLC 13F holdings Q2 2026: $5.4 billion

Orbimed Advisors LLC reported $5.4 billion in 13F securities across 128 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Edgewise Therapeutics Inc at $631 million, 11.7% of the reported value. Since Q1 2026 it opened 42 new positions and exited 26.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $5,366,504,294
- Positions: 128
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1055951
- Form 13F file number: 028-06774
- CRD number: 118608
- Business address: 601 Lexington Avenue 54th Floor, New York, NY 10022
- SEC filing: [0001172661-26-003740](https://www.sec.gov/Archives/edgar/data/1055951/000117266126003740/0001172661-26-003740-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/orbimed-advisors-llc-118608)

## Top 25 holdings by value

The largest of 128 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Edgewise Therapeutics Inc](https://specstream.ai/data/institutional-holders/edgewise-therapeutics-inc-28036f105) | COM | 15,518,492 | $630.5 million | No change |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 6,776,632 | $343.9 million | -1,182,906 |
| [Eli Lilly & Co](https://specstream.ai/data/institutional-holders/eli-lilly-co-532457108) | COM | 257,900 | $309.3 million | +21,100 |
| [MBX Biosciences Inc](https://specstream.ai/data/institutional-holders/mbx-biosciences-inc-55287l101) | COM | 3,428,736 | $189.3 million | -209,151 |
| [Sinovac Biotech LTD](https://specstream.ai/data/institutional-holders/sinovac-biotech-ltd-p8696w104) | SHS | 2,718,735 | $184.5 million | No change |
| [Astrazeneca PLC](https://specstream.ai/data/institutional-holders/astrazeneca-plc-g0593m107) | ORD | 915,700 | $171.1 million | +245,500 |
| [Structure Therapeutics Inc](https://specstream.ai/data/institutional-holders/structure-therapeutics-inc-86366e106) | SPONSORED ADS | 2,209,400 | $118.6 million | +733,997 |
| [Sionna Therapeutics Inc](https://specstream.ai/data/institutional-holders/sionna-therapeutics-inc-829401108) | COM | 2,555,877 | $112.4 million | -974,825 |
| [Corvus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/corvus-pharmaceuticals-inc-221015100) | COM | 7,165,006 | $107 million | No change |
| [Arrivent Biopharma Inc](https://specstream.ai/data/institutional-holders/arrivent-biopharma-inc-04272n102) | COM | 3,027,328 | $105.2 million | No change |
| [Guardant Health Inc](https://specstream.ai/data/institutional-holders/guardant-health-inc-40131m109) | COM | 583,700 | $87.6 million | +148,500 |
| [Argenx Se](https://specstream.ai/data/institutional-holders/argenx-se-04016x101) | SPONSORED ADR | 92,880 | $86.2 million | -44,020 |
| [Merck & Co Inc](https://specstream.ai/data/institutional-holders/merck-co-inc-58933y105) | COM | 663,400 | $85.2 million | No change |
| [Uniqure NV](https://specstream.ai/data/institutional-holders/uniqure-nv-n90064101) | SHS | 1,807,486 | $83.3 million | -328,663 |
| [Praxis Precision Medicines I](https://specstream.ai/data/institutional-holders/praxis-precision-medicines-i-74006w207) | COM NEW | 230,100 | $77 million | +57,600 |
| [Edwards Lifesciences Corp](https://specstream.ai/data/institutional-holders/edwards-lifesciences-corp-28176e108) | COM | 834,900 | $75.5 million | -395,700 |
| [Prelude Therapeutics Inc](https://specstream.ai/data/institutional-holders/prelude-therapeutics-inc-74065p101) | COM | 13,724,571 | $73.2 million | +2,815,315 |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 546,522 | $72.8 million | +80,822 |
| [Dyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/dyne-therapeutics-inc-26818m108) | COM | 3,235,684 | $71.9 million | +317,800 |
| [Natera Inc](https://specstream.ai/data/institutional-holders/natera-inc-632307104) | COM | 262,000 | $71.1 million | No change |
| [CG Oncology Inc](https://specstream.ai/data/institutional-holders/cg-oncology-inc-156944100) | COM | 972,800 | $69.1 million | +24,533 |
| [Unitedhealth Group Inc](https://specstream.ai/data/institutional-holders/unitedhealth-group-inc-91324p102) | COM | 161,100 | $67 million | New |
| [Ars Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ars-pharmaceuticals-inc-82835w108) | COM | 8,288,510 | $66.4 million | No change |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 244,456 | $65.2 million | New |
| [Humana Inc](https://specstream.ai/data/institutional-holders/humana-inc-444859102) | COM | 164,100 | $65.2 million | New |

## New positions in Q2 2026

42 positions not in the filing for the quarter ended March 31, 2026. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Unitedhealth Group Inc](https://specstream.ai/data/institutional-holders/unitedhealth-group-inc-91324p102) | COM | 161,100 | $67 million |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 244,456 | $65.2 million |
| [Humana Inc](https://specstream.ai/data/institutional-holders/humana-inc-444859102) | COM | 164,100 | $65.2 million |
| [Odyssey Therapeutics Inc](https://specstream.ai/data/institutional-holders/odyssey-therapeutics-inc-67613t104) | COMMON STOCK | 3,001,198 | $56.2 million |
| [Arcutis Biotherapeutics Inc](https://specstream.ai/data/institutional-holders/arcutis-biotherapeutics-inc-03969k108) | COM | 2,042,000 | $53.5 million |
| SPDR Series Trust | ST STR SP BIOT (put) | 300,000 | $47.5 million |
| Abivax SA | SPONSORED ADS (call) | 200,000 | $26.7 million |
| [West Pharmaceutical SVSC Inc](https://specstream.ai/data/institutional-holders/west-pharmaceutical-svsc-inc-955306105) | COM | 70,600 | $25.3 million |
| [Aura Biosciences Inc](https://specstream.ai/data/institutional-holders/aura-biosciences-inc-05153u107) | COM | 3,333,333 | $23.7 million |
| Protagonist Therapeutics Inc | COM (call) | 150,000 | $18.4 million |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 186,145 | $16.5 million |
| [Waters Corp](https://specstream.ai/data/institutional-holders/waters-corp-941848103) | COM | 40,300 | $15.1 million |
| [Monopar Therapeutics Inc](https://specstream.ai/data/institutional-holders/monopar-therapeutics-inc-61023l207) | COM NEW | 157,423 | $14.6 million |
| [Travere Therapeutics Inc](https://specstream.ai/data/institutional-holders/travere-therapeutics-inc-89422g107) | COM | 253,000 | $14.4 million |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 2,000,000 | $13.6 million |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 115,000 | $11.2 million |
| [Spruce Biosciences Inc](https://specstream.ai/data/institutional-holders/spruce-biosciences-inc-85209e208) | COM NEW | 200,000 | $10.8 million |
| Revolution Medicines Inc | COM (call) | 50,000 | $9.4 million |
| [Erasca Inc](https://specstream.ai/data/institutional-holders/erasca-inc-29479a108) | COM | 495,900 | $9.1 million |
| [Protara Therapeutics Inc](https://specstream.ai/data/institutional-holders/protara-therapeutics-inc-74365u107) | COM STK | 2,220,000 | $8.5 million |
| [Zentalis Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/zentalis-pharmaceuticals-inc-98943l107) | COM | 1,390,576 | $6.7 million |
| [Travere Therapeutics Inc](https://specstream.ai/data/institutional-holders/travere-therapeutics-inc-89422gab3) | NOTE 0.500% 5/1 (principal) | 5,000,000 | $5.9 million |
| [Xilio Therapeutics Inc](https://specstream.ai/data/institutional-holders/xilio-therapeutics-inc-98422t209) | COM | 592,300 | $5.7 million |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155xaa8) | NOTE 0.500% 5/0 (principal) | 3,500,000 | $4.4 million |
| Unitedhealth Group Inc | COM (call) | 10,000 | $4.2 million |

## Positions exited in Q2 2026

26 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Mdxhealth SA | SHS NEW (call) | 124,306,000 | $285.9 million |
| Avita Medical Inc | COM (call) | 40,966,100 | $154.4 million |
| [Myriad Genetics Inc](https://specstream.ai/data/institutional-holders/myriad-genetics-inc-62855j104) | COM (principal) | 125,000,000 | $122.9 million |
| [Pfizer Inc](https://specstream.ai/data/institutional-holders/pfizer-inc-717081103) | COM | 1,946,500 | $54.7 million |
| [Danaher Corp Del](https://specstream.ai/data/institutional-holders/danaher-corp-del-235851102) | COM | 265,800 | $50.4 million |
| Ascendis Pharma A/S | SPONSORED ADR | 181,977 | $41.6 million |
| [Avita Medical Inc](https://specstream.ai/data/institutional-holders/avita-medical-inc-05380c102) | COM (principal) | 40,500,000 | $40.5 million |
| [Esperion Therapeutics Inc Ne](https://specstream.ai/data/institutional-holders/esperion-therapeutics-inc-ne-29664w105) | COM | 10,570,300 | $29 million |
| [Brightspring Health SVCS Inc](https://specstream.ai/data/institutional-holders/brightspring-health-svcs-inc-10950a106) | COM | 497,800 | $21.2 million |
| [Amgen Inc](https://specstream.ai/data/institutional-holders/amgen-inc-031162100) | COM | 39,900 | $14 million |
| [Alignment Healthcare Inc](https://specstream.ai/data/institutional-holders/alignment-healthcare-inc-01625v104) | COM | 791,000 | $13.9 million |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/institutional-holders/regeneron-pharmaceuticals-75886f107) | COM | 14,700 | $11.4 million |
| [Carlsmed Inc](https://specstream.ai/data/institutional-holders/carlsmed-inc-14280c105) | COM | 1,252,600 | $11.3 million |
| Qiagen NV | ORD SHARES (call) | 250,000 | $10 million |
| [Gilead Sciences Inc](https://specstream.ai/data/institutional-holders/gilead-sciences-inc-375558103) | COM | 59,600 | $8.3 million |
| [Heron Therapeutics Inc](https://specstream.ai/data/institutional-holders/heron-therapeutics-inc-427746102) | COM | 9,816,940 | $7.9 million |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 475,165 | $7.1 million |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 1,150,646 | $6.4 million |
| [Adc Therapeutics SA](https://specstream.ai/data/institutional-holders/adc-therapeutics-sa-h0036k147) | SHS | 1,318,026 | $4.9 million |
| [Cullinan Therapeutics Inc](https://specstream.ai/data/institutional-holders/cullinan-therapeutics-inc-230031106) | COM | 243,006 | $3.5 million |
| Soleno Therapeutics Inc | COM (call) | 100,000 | $3.3 million |
| [Jade Biosciences Inc](https://specstream.ai/data/institutional-holders/jade-biosciences-inc-008064206) | COM NEW | 185,011 | $2.6 million |
| [C4 Therapeutics Inc](https://specstream.ai/data/institutional-holders/c4-therapeutics-inc-12529r107) | COM STK | 856,353 | $2.3 million |
| [Avita Medical Inc](https://specstream.ai/data/institutional-holders/avita-medical-inc-05380c102) | COM | 544,895 | $2 million |
| Kalvista Pharmaceuticals Inc | COM | 94,400 | $1.9 million |

## Also on SpecStream

- [Orbimed Advisors LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1055951/000117266126003740/0001172661-26-003740-index.htm)
- [Orbimed Advisors LLC investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/orbimed-advisors-llc-118608)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Buffet restaurants in New York, New York](https://specstream.ai/data/businesses/buffet-restaurants/new-york-new-york-united-states)
- [Middle Eastern restaurants in New York, New York](https://specstream.ai/data/businesses/middle-eastern-restaurants/new-york-new-york-united-states)
- [Building contractors in New York, New York](https://specstream.ai/data/businesses/building-contractors/new-york-new-york-united-states)
- [Middle schools in New York, New York](https://specstream.ai/data/businesses/middle-schools/new-york-new-york-united-states)
- [Building supply stores in New York, New York](https://specstream.ai/data/businesses/building-supply-stores/new-york-new-york-united-states)
- [Mortgage brokers in New York, New York](https://specstream.ai/data/businesses/mortgage-brokers/new-york-new-york-united-states)
